NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative, a research partnership between the European Commission and European pharmaceutical companies, will grant €156.3 million ($231.9 million) to researchers in its upcoming second funding call.

The IMI was created in 2007 to accelerate discovery and development of new drugs for cancer, inflammatory diseases, and infectious diseases by addressing important research bottlenecks in the process.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.